Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CME Outfitters

Minimizing the Burden of Prior Authorization in AMD Through Actionable Strategies and Improved Communication

Access Activity

Overview / Abstract:

The development of anti–vascular endothelial growth factor (VEGF) agents has revolutionized the treatment of age-related macular degeneration (AMD). Nevertheless, optimal management of AMD is impeded by challenges in access to FDA-approved therapies. Step therapy, a type of prior authorization (PA) instituted by the payer, mandates that more cost-effective therapies be used before more expensive alternatives, in a stepwise approach. However, applying this strategy to vision-threatening diseases such as AMD often leads to treatment delays and increases the risk of disease progression.

In order to decrease the burden of PA for AMD treatments, the second module of this CME Outfitters Snack series aims to provide learners with strategies to improve documentation and establish clear communication with the payer to minimize treatment delays.


Nov 21, 2020


Nurse Practitioner , Nursing CNE, Optometry / Ophthalmology CE, Pharmacy CPE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™/contact hours/CEUs



Presenters / Authors / Faculty

Darius M. Moshfeghi, MD
Professor and Chief, Retina Division
Horngren Family Vitreoretinal Center
Byers Eye Institute, Department of Ophthalmology
Stanford University School of Medicine
Stanford, CA

Derek van Amerongen, MD, MS
Vice President and Medical Officer
Humana of Ohio
Springdale, OH

Sponsors / Supporters / Grant Providers

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Keywords / Search Terms

CME Outfitters, LLC ophthalmology, optometry, optical, retinal, AMD, macular degeneration Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.